Replacing Refined Carbohydrates With Healthy Fats on Cardio-metabolic Markers
NCT ID: NCT02695433
Last Updated: 2021-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2016-03-01
2021-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk
NCT02479048
Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes
NCT00108459
Effect of Low Carbohydrate Versus Low Fat Diet in the Treatment of Dyslipidemia in Obese Children With Metabolic Syndrome
NCT03937960
Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health
NCT00200720
Incorporating Avocados in Meals
NCT01271829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The trial will test 2 treatment conditions in pre-diabetic men and women 25-60 years of age with metabolic syndrome. One hundred twenty men and women will be recruited, aiming for a completer set of 96 subjects. Qualified Subjects will be randomized to receive 1 of 2 test treatments based on randomization schedule from a computer generated randomization schedule.
Study treatments include:
* Control (CT) diet plan with at least 1 serving of a low fat, low fiber, high glycemic carbohydrate and eliminate avocado 7 days / week (5-7 days is acceptable) over a 12 week period.
* Active treatment (AT) diet plan will include 1 Avocado 7 days/week (5-7 days is acceptable) over a 12 week period.
Each subject will be asked to come for one Screening Visit, 9 interim food pick-up/compliance visits and 4 Test Day Visits. The four main Test Day visits will occur at week 0 (day 1; baseline), end of week 4, at the end of week 8 and at the end of week 12. Interim Visits will occur at week 1, 2, 3, 5, 6, 7, 9, 10 and 11. Subjects will pick-up study foods, answer questionnaires, receive dietary counseling, confirm diet compliance during interim visits. They will also be asked to complete online 24 hour food recalls up to once per each week of the study. Each of the 4 Test Day Visits will last about 2-3.5 h and involve blood pressure (BP) measurements, a fasting blood sample collection and anthropometric, body composition assessment. In addition, an oral glucose tolerance test (OGTT) will be performed at week 0/day 1 and at the end of week 12/day.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active treatment (AT) diet plan
1 Avocado 7 days/week (5-7 days is acceptable) over a 12 week period
Active
Active Treatment Diet Plan
Control (CT) diet plan
at least 1 serving of a low fat, low fiber, high glycemic carbohydrate and eliminate avocado 7 days / week (5-7 days is acceptable) over a 12 week period
Control
Control Diet Plan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active
Active Treatment Diet Plan
Control
Control Diet Plan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI of 25 - 42 kg/m2
* HOMA-IR ≥ 2
* Abdominal obesity: mid-point waist circumference \>102 cm for men and \>88 cm for women
* No clinical evidence / history of heart disease, respiratory, renal, gastrointestinal, or hepatic disease
* Not taking over-the-counter or prescription medications/dietary supplements that may interfere with study procedures or endpoints (e.g., antioxidant supplements, protein powder, energy drinks, anti-inflammatory or lipid-lowering medications).
* Non-smoker or past smoker (smoking cessation \> 2 yrs.)
* Able to provide informed consent and comply with study procedures
Exclusion Criteria
* BMI \< 25 kg/m2 or \> 42 kg/m2
* HOMA-IR \< 2.0
* History of heart disease, respiratory, renal, gastrointestinal or hepatic disease
* Diabetes
* Have or had cancer other than non-melanoma skin cancer in past 5 years
* Taking over-the-counter or prescription medications or dietary supplements that may interfere with study procedures or endpoints (including protein powers, energy drinks)
* Vegan dietary habits, unusual dietary habits or sensitive or allergic to any of the test meal components / ingredients
* Consuming 3 or more avocados per week.
* Consuming 3 or more servings of nuts or peanuts per week, unless subject is willing to stop consuming nuts 4 weeks before and throughout the course of the study.
* Excessive coffee and tea consumers (\>4 cups/day)
* Current smoker
* Actively losing weight or trying to lose weight (unstable body weight fluctuations of \> 5 kg in 3 months
* Drug or alcohol addiction
* Present with significant psychiatric or neurological disturbances
* Working overnight (e.g 3rd shift of overnight workers)
* Pregnant, lactating or planning to become pregnant
* Have donated blood within 3 months of the screening visit and blood donors/participants for whom participation in this study will result in having donated more than 1500 milliliters of blood in the previous 12 months.
* Women who are taking unstable dose and brand of hormonal contraceptive and/or stable dose and brand less than 6 months
* Excessive exercisers or trained athletes
* Take part in chronic feeding or medication clinical trial in the last 3 months
25 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Nutrition Research Center, Illinois Institute of Technology
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Britt Britt Burton-Freeman, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Illinois Institute of Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Nutrition Research Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang X, Xiao D, Guzman G, Edirisinghe I, Burton-Freeman B. Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance. J Nutr. 2022 Aug 9;152(8):1851-1861. doi: 10.1093/jn/nxac126.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB2016-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.